Hyperinsulinemia, a hallmark of insulin resistance in T2D, results in sustained activation of insulin receptors—particularly the mitogenic insulin receptor isoform A—and increases circulating levels of insulin-like growth factor 1 (IGF-1) [7,8]. This evidence concerns the gene IGF1 and Hyperinsulinemia.